Skip to main content

MoneyWorks4Me

Gufic Biosciences informs about outcome of board meeting

25 Nov 2016 Evaluate

Gufic Biosciences has informed that the Board of Directors of the Company at its meeting held on November 24, 2016, has approved the Scheme of Amalgamation of Gufic Stridden Bio-Pharma with the Company, subject to the necessary approvals.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1877.45
Dr. Reddys Labs. 1383.10
Cipla 1403.80
Lupin 2016.50
Zydus Lifesciences 1198.15
View more..